Knowledge Library
Target to Hit Finding: New Methods in Fragment-Based Drug Discovery
Enable Pharma and Biotech Innovation through Open-Access Platform
Fragment Screening and Biophysical Hit Validation at WuXi AppTec’s HitS
Enabling Technologies for Targeted Protein Degradation Webinar
Enabling Technologies For Bifunctional Molecule Discovery And Characterization
Cancer Immunotherapy and the Application of In Vitro Immunoassays in Drug Development
Optimizing Drug Discovery Pipelines with Biophysical Methods
Validation of GVHD in mouse model for preclinical efficacy screen
AACR Annual meeting 2021 Na Xu, Ya Zhang, Rou Xie, Lijun Jia, Yingying Cai, Qing Lin Oncology and Immunology Unit, WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China Background Bone marrow transplantation has been successfully and widely used to treat diseases such as leukemia and lymphomas. However, the complication Graft …Read More >
Faster with high-speed fragment screening — Accelerate your drug discovery campaign
In the past, thousands of proteins were considered undruggable. The restricted number of chemical entities available and classical methods limited the exploration of this undevelopable area. Today, the combination of novel chemical modalities and advanced technical approaches has resulted in new clinical candidates from previously undruggable targets. To accelerate your drug discovery campaign, WuXi AppTec´s …Read More >
